Publication | Open Access

N-Hydroxy-1,2-disubstituted-1H-benzimidazol-5-yl acrylamides as novel histone deacetylase inhibitors: Design, synthesis, SAR studies, and in vivo antitumor activity

Medicinal ChemistryMedicineN-hydroxy-1,2-disubstituted-1h-benzimidazol-5-yl AcrylamidesVivo Antitumor ActivityPharmacotherapyAnti-cancer AgentDrug DevelopmentPharmacologyRadiation OncologyPharmaceutical ChemistrySar StudiesDrug Discovery